E-resources
PDF-
Samaras, Panagiotis; Bauer, Stefan; Stenner-Liewen, Frank; Steiner, Rudolf; Zweifel, Martin; Renner, Christoph; Knuth, Alexander
Haematologica (Roma), 10/2007, Volume: 92, Issue: 10Journal Article
We report a case of POEMS syndrome which relapsed six years after autologous peripheral blood stem cell transplantation. According to encouraging data published recently, we treated the patient with cyclophosphamide, dexamethasone and the VEGF-antibody bevacizumab. After an initial improvement, the subsequent course was complicated by severe adverse events leading to multiorgan failure and death. This dramatic decline highlights the need for further investigation before using bevacizumab in patients with POEMS syndrome.
